Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Personalized Medicine Biomarkers Market, by Region, 2019-2029 (USD Billion)
1.2.2. Personalized Medicine Biomarkers Market, by Indication, 2019-2029 (USD Billion)
1.2.3. Personalized Medicine Biomarkers Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Personalized Medicine Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Personalized Medicine Biomarkers Market Dynamics
3.1. Personalized Medicine Biomarkers Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising awareness and significance of analyzing the prognosis and selection of dose
3.1.1.2. Surging demand for personalized medicine
3.1.2. Market Challenges
3.1.2.1. Regulatory & reimbursement hurdles
3.1.2.2. High capital investments and lengthy timelines for biomarker development
3.1.3. Market Opportunities
3.1.3.1. Growing investment in research & development activities
3.1.3.2. Technological advancements in the diagnosis and detection of chronic diseases
Chapter 4. Global Personalized Medicine Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Personalized Medicine Biomarkers Market, by Indication
6.1. Market Snapshot
6.2. Global Personalized Medicine Biomarkers Market by Indication, Performance – Potential Analysis
6.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
6.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Diabetes
6.4.3. Autoimmune Diseases
6.4.4. Cardiology
6.4.5. Others
Chapter 7. Global Personalized Medicine Biomarkers Market, by Application
7.1. Market Snapshot
7.2. Global Personalized Medicine Biomarkers Market by Application, Performance – Potential Analysis
7.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
7.4.1. Early Detection/Screening
7.4.2. Diagnosis
7.4.3. Treatment Selection
7.4.4. Monitoring
Chapter 8. Global Personalized Medicine Biomarkers Market, Regional Analysis
8.1. Personalized Medicine Biomarkers Market, Regional Market Snapshot
8.2. North America Personalized Medicine Biomarkers Market
8.2.1. U.S. Personalized Medicine Biomarkers Market
8.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Personalized Medicine Biomarkers Market
8.3. Europe Personalized Medicine Biomarkers Market Snapshot
8.3.1. U.K. Personalized Medicine Biomarkers Market
8.3.2. Germany Personalized Medicine Biomarkers Market
8.3.3. France Personalized Medicine Biomarkers Market
8.3.4. Spain Personalized Medicine Biomarkers Market
8.3.5. Italy Personalized Medicine Biomarkers Market
8.3.6. Rest of Europe Personalized Medicine Biomarkers Market
8.4. Asia-Pacific Personalized Medicine Biomarkers Market Snapshot
8.4.1. China Personalized Medicine Biomarkers Market
8.4.2. India Personalized Medicine Biomarkers Market
8.4.3. Japan Personalized Medicine Biomarkers Market
8.4.4. Australia Personalized Medicine Biomarkers Market
8.4.5. South Korea Personalized Medicine Biomarkers Market
8.4.6. Rest of Asia Pacific Personalized Medicine Biomarkers Market
8.5. Latin America Personalized Medicine Biomarkers Market Snapshot
8.5.1. Brazil Personalized Medicine Biomarkers Market
8.5.2. Mexico Personalized Medicine Biomarkers Market
8.5.3. Rest of Latin America Personalized Medicine Biomarkers Market
8.6. Rest of The World Personalized Medicine Biomarkers Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Laboratory Corporation of America Holding
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Quest Diagnostics Incorporated
9.2.3. Agilent Technologies, Inc.
9.2.4. Genome Medical, Inc.
9.2.5. Coriell Life Sciences.
9.2.6. Thermo Fisher Scientific Inc.
9.2.7. NeoGenomics Laboratories
9.2.8. Foundation Medicine, Inc.
9.2.9. Illumina, Inc.
9.2.10. Guardant Health
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption